The Economic Costs of Type 2 Diabetes: A Global Systematic Review.

ABSTRACT:

Background

There has been a widely documented and recognized increase in diabetes prevalence, not only in high-income countries (HICs) but also in low- and middle-income countries (LMICs), over recent decades. The economic burden associated with diabetes, especially in LMICs, is less clear.

Objective

We provide a systematic review of the global evidence on the costs of type 2 diabetes. Our review seeks to update and considerably expand the previous major review of the costs of diabetes by capturing the evidence on overall, direct and indirect costs of type 2 diabetes worldwide that has been published since 2001. In addition, we include a body of economic evidence that has hitherto been distinct from the cost-of-illness (COI) work, i.e. studies on the labour market impact of

SUBMITTER: Seuring T 

PROVIDER: S-EPMC4519633 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature